Surveillance of Efficacy and Tolerability in Von Willebrand's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN63533506

Enrollment

Registered

2008-11-19

Start date

2005-02-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Von Willebrand's disease Haematological Disorders Other coagulation defects

Interventions

Documentation of details of diagnosis and bleeding frequency at entry, details of bleeding episodes and surgical procedures during 2-year individual observation period. Documentation of details of eac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients (any age and gender) suffering from hereditary or acquired Von Willebrand's disease requiring von Willebrand factor (VWF)/coagulation factor eight (FVIII) concentrate.

Exclusion criteria

Exclusion criteria: Does not comply with the above inclusion criteria

Design outcomes

Primary

Measure	Time frame
Percentage of efficacy assessments with rating "excellent/good".	—

Secondary

Measure	Time frame
Percentage of tolerability assessments with rating "excellent/good".	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026